Alameda

Sanofi turns to startup Scribe to CRISPR edit new NK cell therapies for cancer

Sanofi is collaborating with Scribe Therapeutics to use the startup’s CRISPR technology to create cell therapies based on natural killers, a type of immune cell that has cancer-killing capabilities. The pharma giant is paying Scribe $25 million up front to kick off the deal.

By Frank Vinluan

BioPharma, Startups

Juvenescence raises $50 million in Series A, buys minority stake in AgeX

Firm invests $5 million in preclinical company developing drugs for age-related degenerative diseases.

By Alaric DeArment

The Top 6 Best Analytics Tools for Health Care Revenue in 2025

Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources.

By Millennia

The Top-Rated Orthopedic Surgery Centers in the Houston Area and Beyond

Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.

By Fondren Orthopedic Group

Navigating The Right Steps For Your Healthcare Startup

This webinar will explore how a banking platform approach could be the resource for your company.

By Mercury and MedCity News